Low CD49d expression in newly diagnosed chronic lymphocytic leukaemia may be associated with high‐risk features and reduced treatment‐free‐intervals

This study was carried out to assess the prognostic power of low CD49d expression (≥10%) in newly diagnosed CLL patients using a previously described cohort. Eighty‐five patients were included. Median age at diagnosis; 70 years (43–88); CD49d was expressed in 33/85 (38.8%); 23/33 (69.7%) at ≥30% ref...

Descripción completa

Detalles Bibliográficos
Autores principales: Elizabeth, Smyth, Aidan, Kelly, David, O' Brien, Deirdre, Waldron, Sarah, Brophy, Emer, Atkinson, Kanthi, Perera, Crotty, Gerard M., Aileen, Walsh, Michelle, Connolly, Ruth, Clifford, Hilary, O'Leary, Ashique, Khan, Bacon, Christopher L., Emily, Smyth, McElligott, Anthony M., Fiona, Quinn, Elisabeth, Vandenberghe, Carmel, Waldron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804520/
https://www.ncbi.nlm.nih.gov/pubmed/35776688
http://dx.doi.org/10.1111/ejh.13824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804520/
https://www.ncbi.nlm.nih.gov/pubmed/35776688
http://dx.doi.org/10.1111/ejh.13824

Ejemplares similares